Journey Medical Corp is not in compliance with Nasdaq Listing Rule 5550(b)(1) and has until February 11, 2024, to regain compliance. The company entered into a license agreement with Maruho Co., Ltd. and received $19 million.
AI Assistant
JOURNEY MEDICAL CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.